Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Bristol-Myers Squibb Aktiebolag
AB
Active
Org 5560929886
Hemvärnsgatan 9, 171 54
Solna
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1964
50-99 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Bristol-Myers Squibb Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1B
2B
3B
4B
2.5B
2020
2.6B
2021
3.1B
2022
3.4B
2023
3.8B
2024
EBITDA
SEK millions
0M
62M
125M
187M
250M
76M
2020
126M
2021
217M
2022
123M
2023
191M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
2 501 570
2 569 740
3 057 747
3 434 702
3 806 648
Staff expenses
—
—
—
—
—
EBITDA
75 718
125 567
216 672
122 508
191 165
Depreciation & amort.
−1 616
−3 971
−4 596
−4 560
−4 483
EBIT
74 102
121 596
212 076
117 948
186 682
Net financials
−5 853
−6 998
−9 644
−33 350
3 574
Profit before tax
68 249
114 598
202 432
84 598
190 256
Tax
−16 544
−25 545
−56 314
−20 191
−51 935
Net profit
51 705
89 053
146 118
64 407
138 321
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 420 318
1 431 648
2 262 332
1 322 943
1 463 364
Equity
387 710
476 763
622 880
683 729
822 051
Long-term debt
0
0
0
0
0
Short-term debt
1 023 844
948 654
1 636 034
638 002
640 654
Total debt
1 023 844
948 654
1 636 034
638 002
640 654
Financial ratios
5-year trend
EBITDA margin
5.0%
This company
15.8%
Market median
-68% vs market
2020
2024
Equity ratio
56.2%
This company
38.2%
Market median
+47% vs market
2020
2024
Return on equity
16.8%
This company
18.4%
Market median
+9% vs market
2020
2024
Net profit margin
3.6%
This company
8.1%
Market median
-56% vs market
2020
2024
Asset turnover
2.60×
This company
1.12×
Market median
+132% vs market
2020
2024
Debt / equity
0.78×
This company
0.62×
Market median
+26% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Bristol-Myers Squibb Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
